Dark Pharma ยท DP-015

She Took The Call On October 19th 2015. She Had Forty Questions. She Could Answer Six.

Every earnings call, every analyst day, mandated a binder filled with prepared responses, but on October 19, 2015, only six out of forty-three questions had scripted answers. The remaining thirty-seven inquiries exposed a gaping hole in Valeant Pharmaceuticals' readiness to manage a financial crisis.

Case Assets

The Case Debrief is free to view. Full Case Study, Teaching Notes, Slide Deck, Discussion Guide, and Assessment are available with a Premium subscription.

Brief the Board PREMIUM
๐Ÿ”’ Unlock
Learn the Case FREE โ€” included
Study the Case PREMIUM
๐Ÿ”’ Unlock
Teach the Case PREMIUM
๐Ÿ”’ Unlock
Present the Case PREMIUM
๐Ÿ”’ Unlock
Run a Team Discussion PREMIUM
๐Ÿ”’ Unlock
Test Your Judgement PREMIUM
๐Ÿ”’ Unlock

Watch the Full Episode

The complete cinematic audio documentary โ€” Dark Pharma

Unlock the Full Case Library

Get every Case Study, Slide Deck, Teaching Notes, Discussion Guide, and Assessment โ€” across a growing library of business cases.

View Pricing โ†’

Related Cases

Cases that share a governance or behavioural model with this one.